actinic keratosis

Type: Keyphrase
Name: actinic keratosis
First reported Apr 24 2014 - Updated Apr 24 2014 - 1 reports

La Roche-Posay announces research award winners

Skincare product manufacturer La Roche-Posay has announced the recipients of the ninth annual La Roche-Posay North American Foundation 2014 Research Awards, celebrating advances in clinical, biological and pharmacological research advances in the field ... [Published Dermatology Times - Apr 24 2014]
First reported Apr 22 2014 - Updated Apr 23 2014 - 1 reports

ONCOSEC MEDICAL INC : OncoSec Medical Appoints New Executive Director of Research and Development

OncoSec Medical Inc.?s (OTCQB: ONCS) share volume was strong Apr. 21 with 2,910,820 shares changing hands.The surge in stock volume is being spurred in part by the San Diego-based bio-tech company?s announcement that it has appointed Jean S. Campbell, ... [Published 4 Traders - Apr 22 2014]
First reported Apr 22 2014 - Updated Apr 22 2014 - 1 reports

Use of tellurium compounds for the treatment of actinic keratosis

Methods for treating skin conditions such as basal cell carcinoma and/or actinic keratosis are provided, which are effected by administering a pharmaceutically effective amount of a tellurium-containing compound. A pharmaceutical composition for treatment ... [Published Free Patents Online - Apr 22 2014]
First reported Apr 21 2014 - Updated Apr 22 2014 - 2 reports

Foamix Announces the Issuance of Five Additional US Patents

(GLOBE NEWSWIRE) -- Foamix, a clinical-stage, specialty pharmaceutical company, focused on the development, patenting and commercialization of proprietary topical foams and the first topical minocycline/doxycycline antibiotics to address unmet needs in ... [Published Virtual Strategy Magazine - Apr 21 2014]
First reported Apr 20 2014 - Updated Apr 20 2014 - 1 reports

Photo Facial and the Procedure on How It Is Done

The procedure is not an alternate for a face-lift and will not help baggy or sagging skin. The procedure will not cure the puffiness around the eyes for which blepharoplasty surgery is needed. It is not a treatment for skin cancer, but it can eradicate ... [Published Free Press Release - Apr 20 2014]
First reported Apr 18 2014 - Updated Apr 18 2014 - 1 reports

Line of $100 face serums has been awarded a patent for preventing cancer

The new miracle skincare? The $100 face serum line that has been awarded a patent for preventing cancer by repairing DNA A line of face serums has been awarded a U.S. patent for its ability to prevent skin cancer and treat scars and lesions by repairing ... [Published Mail Online UK - Apr 18 2014]
Entities: Serum, Catalyst, Patent
First reported Apr 15 2014 - Updated Apr 16 2014 - 1 reports

Elite Pharmaceuticals to Receive up to 40 Million from Lincoln Park Capital Fund

04/15/2014[ACCESSWIRE]Elite Pharmaceuticals Inc. (OTCBB: ELTP) announced Apr. 14 that it has entered into a common stock purchase agreement with Lincoln Park Capital Fund LLC ("LPC"), a Chicago-based institutional investor for up to $40 million.Proceeds ... [Published Accesswire - Apr 15 2014]
First reported Apr 15 2014 - Updated Apr 15 2014 - 1 reports

Pyrazole derivatives as ERK inhibitors

This invention describes substituted pyrazole derivatives of Formula I and methods of making and using the compounds. These compounds have utility in the treatment of conditions or diseases in which modification of the activity of ERK would have a positive ... [Published Free Patents Online - Apr 15 2014]
First reported Apr 11 2014 - Updated Apr 11 2014 - 1 reports

Accumulate Sun Pharma; target of Rs 646: P Lilladher

Prabhudas Lilladher's report on Sun Pharmaceutical Industries"Sun Pharma acquired Ranbaxy at an all-stock deal of USD 4bn, including equity value of USD 3.2bn and debt of USD 800m. Per deal, Ranbaxy to merge with Sun Pharma at a stock swap ratio of 0.8:1. ... [Published Moneycontrol.com - Apr 11 2014]
First reported Apr 07 2014 - Updated Apr 07 2014 - 1 reports

ESCOBEDO SKIN CENTER IS PLEASED TO BE THE FIRST TO OFFER ThermaFrax

“ The Escobedo Skin Center implements the latest cosmetic strategy by combing the all New Thermage NXT with the Fraxel laser (repair or restore) for synergistic results.The all new FDA-approved Thermage NXT uses mono-polar capacitive coupling to volumetrically ... [Published Free Press Release - Apr 07 2014]
Entities: Fraxel, Thermage, Laser
First reported Apr 01 2014 - Updated Apr 02 2014 - 1 reports

RESTORGENEX : Completes Acquisition of Two Biopharmaceutical Companies

(GLOBE NEWSWIRE) -- RestorGenex Corporation (OTCQB:SMDID), announced today the closing of its acquisition of two biopharmaceuticals companies, Paloma Pharmaceuticals, Inc. and VasculoMedics, Inc. RestorGenex is a biopharmaceutical company with an initial ... [Published 4 Traders - Apr 01 2014]
First reported Mar 18 2014 - Updated Mar 18 2014 - 1 reports

Actinic Keratosis

or Solar Keratosis is a pre-cancerous condition characterized by thick, rough, dry and scaly or crusty patches caused due to long, perennial exposure to sun.The patches or lesions are more commonly seen in fair-skinned and old people and people who are ... [Published MedIndia - Mar 18 2014]

Quotes

The Offering is scheduled to close on or about Apr. 23, 2014 (the " Closing Date "). The Offering is subject to a number of conditions, including, without limitation, receipt of all regulatory approvals."
Patent 8,618,081 – " Compositions, gels, and foams with rheology modulators and uses thereof "
Commenting on the new financing, Elite's President and CEO, Mr. Nasrat HakimHakim said, "This commitment from Lincoln Park helps Elite to develop our range of abuse resistant opioids on an accelerated pace. By investing in the clinical development of our abuse deterrent products, we expect to significantly increase the value of these products in anticipation of future product partnerships. There is a great interest in our technology and, as Elite has done since I started here last August, we will continue to aggressively scale up and complete the clinical studies necessary to file these products as soon as possible. Our first filing is expected to be by year's end."
"While Sun Pharma management believes to achieve USD 250m synergy in three years, we believe that Ranbaxy's single-digit EBITDA margin, forex derivatives, high consultancy costs and high tax rate to be strong hangover in near term. FDA's approval in Nexium and Diovan could provide benefits of USD 300-400m net income in short term. We maintain Accumulate and target price at Rs 646" , says Prabhudas Lilladher research report

More Content

All (21) | News (21) | Reports (0) | Blogs (0) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
La Roche-Posay announces research award winners [Published Dermatology Times - Apr 24 2014]
Use of tellurium compounds for the treatment of... [Published Free Patents Online - Apr 22 2014]
ONCOSEC MEDICAL INC : OncoSec Medical Appoints ... [Published 4 Traders - Apr 22 2014]
Foamix Announces the Issuance of Five Additiona... [Published Virtual Strategy Magazine - Apr 21 2014]
Foamix Announces the Issuance of Five Additiona... [Published Benzinga.com - Apr 21 2014]
Photo Facial and the Procedure on How It Is Done [Published Free Press Release - Apr 20 2014]
Line of $100 face serums has been awarded a pat... [Published Mail Online UK - Apr 18 2014]
Elite Pharmaceuticals to Receive up to 40 Milli... [Published Accesswire - Apr 15 2014]
Pyrazole derivatives as ERK inhibitors [Published Free Patents Online - Apr 15 2014]
The sultan of synthesis [Published RSC - Apr 11 2014]
Accumulate Sun Pharma; target of Rs 646: P Lill... [Published Moneycontrol.com - Apr 11 2014]
ESCOBEDO SKIN CENTER IS PLEASED TO BE THE FIRST... [Published Free Press Release - Apr 07 2014]
RESTORGENEX : Completes Acquisition of Two Biop... [Published 4 Traders - Apr 01 2014]
Adherence: Behaviour explained by evidence [Published pharmaphorum - Mar 18 2014]
Actinic Keratosis [Published MedIndia - Mar 18 2014]
BioLineRx's CEO Discusses Q4 2013 Results - Ear... [Published Seeking Alpha - Mar 17 2014]
Actinic Solar Keratosis Global Clinical Trials ... [Published BioPortfolio - Feb 20 2014]
Physician treatment perceptions in actinic kera... [Published BioPortfolio - Oct 29 2013]
“Old Geezer” Becomes “New Kid” in Pharma Biz [Published PRWeb - Aug 28 2013]
Half Yearly Report [Published TrustNet - Aug 15 2013]
Chemical peels used facial resurfacing can prev... [Published Cleveland Advocate - Jul 09 2013]
1
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.